A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action
- PMID: 27061123
- PMCID: PMC7169148
- DOI: 10.1002/rmv.1879
A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action
Abstract
The entire life cycle of influenza virus involves viral attachment, entry, replication, and release. Previous studies have demonstrated that neuraminidase (NA) is an essential glycoprotein on the surface of influenza virus and that it is responsible for release of progeny virions from the host cell to infect new cells. However, recent studies have also suggested that NA may play other roles in the early stages of the viral life cycle, that is, viral attachment and entry. This review focuses on the new role of NA in the early stages of influenza life cycle and the corresponding development of novel NA inhibitors. Copyright © 2016 John Wiley & Sons, Ltd.
Copyright © 2016 John Wiley & Sons, Ltd.
Conflict of interest statement
The authors have no competing interest.
Figures
Similar articles
-
Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium.J Virol. 2004 Nov;78(22):12665-7. doi: 10.1128/JVI.78.22.12665-12667.2004. J Virol. 2004. PMID: 15507653 Free PMC article.
-
Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.Antiviral Res. 2013 Nov;100(2):460-72. doi: 10.1016/j.antiviral.2013.08.002. Epub 2013 Aug 15. Antiviral Res. 2013. PMID: 23954192
-
Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30. J Virol. 2015. PMID: 26423941 Free PMC article.
-
Anti-influenza drugs and neuraminidase inhibitors.Prog Drug Res. 2001;Spec No:35-77. doi: 10.1007/978-3-0348-7784-8_2. Prog Drug Res. 2001. PMID: 11548210 Review.
-
Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase.Virol J. 2023 Aug 28;20(1):193. doi: 10.1186/s12985-023-02164-2. Virol J. 2023. PMID: 37641134 Free PMC article. Review.
Cited by
-
Drug-Repositioning Approach for the Discovery of Anti-Influenza Virus Activity of Japanese Herbal (Kampo) Medicines In Vitro: Potent High Activity of Daio-Kanzo-To.Evid Based Complement Alternat Med. 2018 Nov 21;2018:6058181. doi: 10.1155/2018/6058181. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30584454 Free PMC article.
-
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.Hum Vaccin Immunother. 2018;14(8):1840-1847. doi: 10.1080/21645515.2018.1462639. Epub 2018 May 14. Hum Vaccin Immunother. 2018. PMID: 29641358 Free PMC article. Review.
-
Influenza Virus Neuraminidase Structure and Functions.Front Microbiol. 2019 Jan 29;10:39. doi: 10.3389/fmicb.2019.00039. eCollection 2019. Front Microbiol. 2019. PMID: 30761095 Free PMC article. Review.
-
Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.PLoS One. 2018 Feb 28;13(2):e0193623. doi: 10.1371/journal.pone.0193623. eCollection 2018. PLoS One. 2018. PMID: 29489903 Free PMC article.
-
Advances in Nucleic Acid Universal Influenza Vaccines.Vaccines (Basel). 2024 Jun 17;12(6):664. doi: 10.3390/vaccines12060664. Vaccines (Basel). 2024. PMID: 38932393 Free PMC article. Review.
References
-
- Organization WH . Pandemic (H1N1) 2009—update 112. 2010.
-
- Update: WHO‐confirmed human cases of avian influenza A (H5N1) infection, November 2003‐May 2008. Weekly Epidemiological Record 2008; 83: 415–420. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources